Iberverin Downregulates GPX4 and SLC7A11 to Induce Ferroptotic Cell Death in Hepatocellular Carcinoma Cells
Biomolecules · 2024
DOI: 10.3390/biom14111407 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Haoying Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, Jiangxi Medical College…. Hauptthemen laut MEDLINE: Phospholipid Hydroperoxide Glutathione Peroxidase, Ferroptosis, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Jiangxi Provincial Natural Science Foundation, Talent Plan of Jiangxi Province of China.
Abstract (Originalsprache)
Ferroptosis, a recently elucidated style of regulated cell death, has emerged as a significant area of investigation in cancer biology. Natural active compounds that have anti-cancer effects are promising candidates for cancer prevention. Iberverin, a natural compound derived from Brassica oleracea var. capitata, has been shown to exert anti-tumor activities in some cancers. However, its role in hepatocellular carcinoma (HCC) cells and the molecular mechanisms are still poorly understood. In this study, we proved that iberverin can induce intracellular reactive oxygen species (ROS) generation to inhibit cell proliferation and initiate ferroptotic cell death in HCC cells, which can be eradicated by the ferroptosis inhibitor ferrostatin-1 (Fer-1) or deferoxamine mesylate (DFO) and ROS scavenger (GSH or NAC). Mechanistically, iberverin treatment can simultaneously downregulate SLC7A11 mRNA level and degrade GPX4 through the ubiquitination pathway, leading to lipid peroxidation and ferroptotic cell death in HCC cells. Significantly, a low dose of iberverin can remarkably increase the sensitivity of HCC cells to ferroptosis induced by canonical ferroptosis inducers RSL3 and imidazole ketone erastin (IKE). This study uncovers a critical function of iberverin in preventing HCC through ferroptosis and provides a promising strategy for HCC treatment either via iberverin alone or in combination with canonical ferroptosis inducers in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang 330031, China.
- Shanxi Academy of Advanced Research and Innovation, Taiyuan 030032, China.
ORCID-Profile: Bolei Dai, Xueli Bian
Förderung
- National Natural Science Foundation of China
- Jiangxi Provincial Natural Science Foundation
- Talent Plan of Jiangxi Province of China
Zitieren
APA
Yang, H., Dai, B., Chen, L., Li, Y., Jin, X., Gao, C., Han, L., & Bian, X. (2024). Iberverin Downregulates GPX4 and SLC7A11 to Induce Ferroptotic Cell Death in Hepatocellular Carcinoma Cells. Biomolecules. https://doi.org/10.3390/biom14111407
Vancouver
Yang H, Dai B, Chen L, Li Y, Jin X, Gao C, et al. Iberverin Downregulates GPX4 and SLC7A11 to Induce Ferroptotic Cell Death in Hepatocellular Carcinoma Cells. Biomolecules. 2024. doi:10.3390/biom14111407
BibTeX
@article{Yang2024,
author = {Yang, Haoying and Dai, Bolei and Chen, Liangjie and Li, Yingping and Jin, Xiaorui and Gao, Chengchang and Han, Linfen and Bian, Xueli},
title = {Iberverin Downregulates GPX4 and SLC7A11 to Induce Ferroptotic Cell Death in Hepatocellular Carcinoma Cells},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14111407}
}
EUVIMED